These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38892029)

  • 1. Molecular Aspects of Cardiometabolic Diseases: From Etiopathogenesis to Potential Therapeutic Targets.
    Bernatova I; Bartekova M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate-induced lactylation and cardiometabolic diseases: From epigenetic regulation to therapeutics.
    Lin J; Ren J
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167247. PubMed ID: 38762059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences.
    Hong SH; Choi KM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory assessment of cardiometabolic risk in overweight and obese children.
    Sypniewska G
    Clin Biochem; 2015 Apr; 48(6):370-6. PubMed ID: 25583095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome.
    American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee
    Endocr Pract; 2005; 11(2):126-34. PubMed ID: 15915567
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correlation between insulin resistance and puberty in children with increased cardiometabolic risk].
    Tobisch B; Blatniczky L; Barkai L
    Orv Hetil; 2011 Jul; 152(27):1068-74. PubMed ID: 21676673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal exposure to maternal obesity: Lasting cardiometabolic impact on offspring.
    Kislal S; Shook LL; Edlow AG
    Prenat Diagn; 2020 Aug; 40(9):1109-1125. PubMed ID: 32643194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy.
    Gómez-Ambrosi J; Catalán V; Rodríguez A; Andrada P; Ramírez B; Ibáñez P; Vila N; Romero S; Margall MA; Gil MJ; Moncada R; Valentí V; Silva C; Salvador J; Frühbeck G
    Diabetes Care; 2014 Oct; 37(10):2813-21. PubMed ID: 25011950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight and obesity: the pathogenesis of cardiometabolic risk.
    Bray GA; Clearfield MB; Fintel DJ; Nelinson DS
    Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of subcutaneous abdominal and visceral adipose tissue on cardiometabolic risk.
    Sam S
    Horm Mol Biol Clin Investig; 2018 Mar; 33(1):. PubMed ID: 29522417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupted branched-chain amino acid catabolism impair cardiac insulin signaling and is associated with adverse cardiometabolic outcomes.
    Biswas D; Pulinilkunnil T
    J Mol Cell Cardiol; 2021 Apr; 153():93-94. PubMed ID: 33378687
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of tobacco smoking on lipid metabolism, body weight and cardiometabolic risk.
    Gastaldelli A; Folli F; Maffei S
    Curr Pharm Des; 2010; 16(23):2526-30. PubMed ID: 20550509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complement system in human cardiometabolic disease.
    Hertle E; Stehouwer CD; van Greevenbroek MM
    Mol Immunol; 2014 Oct; 61(2):135-48. PubMed ID: 25017306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects and significance of estradiol in men].
    Tőke J; Czirják G; Bezzegh A; Vásárhelyi B; Rácz K; Patócs A
    Orv Hetil; 2014 Jun; 155(23):891-6. PubMed ID: 24880967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking resistin, inflammation, and cardiometabolic diseases.
    Park HK; Kwak MK; Kim HJ; Ahima RS
    Korean J Intern Med; 2017 Mar; 32(2):239-247. PubMed ID: 28192887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Mitochondrial Dysfunction a Common Root of Noncommunicable Chronic Diseases?
    Diaz-Vegas A; Sanchez-Aguilera P; Krycer JR; Morales PE; Monsalves-Alvarez M; Cifuentes M; Rothermel BA; Lavandero S
    Endocr Rev; 2020 Jun; 41(3):. PubMed ID: 32179913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and cardiometabolic risk factors and diseases.
    Mousa A; Naderpoor N; Teede HJ; De Courten MP; Scragg R; De Courten B
    Minerva Endocrinol; 2015 Sep; 40(3):213-30. PubMed ID: 25714787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptors in cardiovascular and metabolic disease.
    Geyeregger R; Zeyda M; Stulnig TM
    Cell Mol Life Sci; 2006 Mar; 63(5):524-39. PubMed ID: 16389454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-Out of
    Wang C; Calcutt MW; Ferguson JF
    Front Endocrinol (Lausanne); 2021; 12():710698. PubMed ID: 34484123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.